Biovara approves share capital split prior to fund raising

12 June, 2025|

The issued share capital of Biovara has been increased to 8 million ordinary shares.

Related news

Biovara to merge with Nuformix Plc

Biovara closes a £ 1 million equity capital raise at an £ 8m pre-money valuation.

Professor Jaclyn Smith – regarded as world leading expert on chronic cough, including Lung Cancer Cough, endorses Biovara’s clinical approach